How Much Does 2.4mg Wegovy Cost in the UK?

The myth: the monthly pen price is what Wegovy costs you

Most searches for Wegovy pricing land on a per-pen figure and treat it as the final answer. It isn't. The pen price published by a private pharmacy is often just the medicine itself, stripped of everything else the treatment actually requires. A clinical consultation, the prescription, delivery and any aftercare or dose-review support may all sit outside that number, billed separately or not offered at all.

Eli Lilly raised Mounjaro's UK list price significantly from September 2025, and Novo Nordisk's pricing has tracked similar market shifts. Reported private prices for Wegovy at 2.4mg have broadly ranged from around £149 to £375 per month across providers since then, though if you want to understand what drives that variation our page on what the 2.4mg Wegovy dose actually costs breaks down the factors in detail. Those figures are a starting point, not a shopping list. For a fuller picture of how Wegovy pricing works across the dose schedule, our guide to Wegovy costs in the UK covers the wider context.

The more useful question isn't "what's the cheapest pen?" but "what am I actually getting for this money, and is it clinically sound?" For a prescription medicine that requires ongoing titration, monitoring and prescriber involvement, the pen price and the treatment cost are two different things.

What the headline price usually leaves out

When you're comparing Wegovy costs across providers, it's worth reading what the quoted price does and doesn't include. Common omissions:

Consultation fees. Some services charge separately for the initial clinical assessment and for each follow-up. On a multi-month course, those add up quickly.

Prescription charges. A private prescription is legally required. Some pharmacies include it; others don't state this clearly upfront.

Delivery costs. Next-day tracked delivery for a temperature-sensitive injectable medicine isn't free everywhere.

Dose titration reviews. Moving through the Wegovy schedule from the starting dose up to 2.4mg involves multiple prescriber decisions. If each review is billed separately, your effective monthly cost rises with each step. For context on how the 1.7mg to 2.4mg transition works in practice and what it costs, see our page on Wegovy 1.7mg pricing.

Aftercare access. Questions arise mid-treatment. Knowing there's someone clinical to contact seven days a week is worth something. Whether that's included or billable varies by provider.

None of this is designed to mislead; it's just how pricing works when you're comparing across a market with no standard structure. Reading the small print before you commit is sensible.

What nume charges and why we're not trying to win on price

Frankly, we're not the cheapest. That's a deliberate position, not an oversight. One transparent price at nume covers the consultation, prescription, medicine, free next-working-day DPD delivery (order by 12pm, once approved — which for plenty of patients means it's there before the end of the next working day) and seven-day aftercare. Nothing is billed separately afterward. There are no subscriptions and no auto-renewals: every repeat order is clinically re-reviewed before it goes out.

Current treatment pricing is on our treatment page rather than listed in body copy, because the right price for you depends on the dose your prescriber confirms is appropriate. We don't print per-pen figures here. What we will say is that the all-in total, once you account for what's included, compares differently from a headline-only number. If you want a straightforward overview of what Wegovy tends to cost across the market, our guide to Wegovy price in the UK pulls together what you need to know before making a decision.

If you'd like to understand how the monthly cost plays out across the full dose schedule, our Wegovy monthly cost breakdown explains how the figures shift as the dose changes. And if you're weighing up semaglutide against other weight-loss medicines, our semaglutide cost guide sets out the broader picture.

Why 'cheapest' is the wrong test for a prescription medicine

Wegovy is a Prescription Only Medicine, classified as such under UK law precisely because it requires professional clinical judgement before and during use. The NHS's guidance on semaglutide sets out the side effects, interactions and situations where treatment needs careful prescriber involvement. That's not bureaucratic caution; it's clinical reality.

The MHRA has warned repeatedly about fake weight-loss pens circulating online (some containing insulin instead of semaglutide, others containing nothing therapeutic at all) sold by unverified sources, sometimes through social media, sometimes accompanied by deeply discounted prices or offers that no regulated pharmacy could legitimately make. Any seller offering Wegovy without requiring a valid prescription is breaking UK law and putting buyers at serious risk. You can verify whether any online pharmacy is properly registered at the GPhC register.

The metric that actually matters for a medicine like this is clinical legitimacy: genuine supply chain, real prescriber oversight, and a pharmacy that stands behind what it dispenses. Price is a fair thing to consider. It just shouldn't be the deciding factor. If you'd like to start your free consultation with our team, there's no cost for the assessment itself.